Author: Sarah Collins

Disclosure: I am in full compliance with all ethics and other policies for Market Realist research analysts. I am not invested in securities that I cover on Market Realist.

Of the 19 analysts covering Hologic, ~63% have a “buy” or “strong buy” rating on the stock.

In 4Q17, Dentsply Sirona (XRAY) started reporting its operations under two segments, after a shift to three segments in fiscal 3Q17.

In 4Q17, Align Technology (ALGN) registered sales of $421.3 million, representing a YoY (year-over-year) growth of 43.7%.

Sirtex Medical Systems is an Australia-based life sciences company with a presence around the globe. The company is focused on interventional oncology therapies.

The Chinese market is Align Technology's major growth driver. However, the company is starting to witness strong competition from startups focused on the clear aligners market.

On December 6, 2017, Varian Medical Systems (VAR) announced that it had received ANVISA registration in Brazil for its Halcyon system.

On December 20, 12 of 24 analysts surveyed by Reuters rated Medtronic (MDT) stock as a "buy," and the remaining 12 analysts recommended a "hold." There were no "sell" ratings given to MDT stock.

Varian Medical Systems (VAR) registered a YoY (year-over-year) sales decline of ~1% in fiscal 4Q17, which was reported on October 25, 2017.

Halcyon is the company's new treatment platform for cancer patients that visually enhances and simplifies image-guided radiotherapy treatments (or IMRT).